Rates of serious infections and malignancies among rheumatoid arthritis patients receiving either TNF blocker or rituximab therapy

: Aaltonen KJ, Joensuu JT, Virkki L, Sokka T, Relas H, Valleala H, Rantalaiho V, Pirila L, Puolakka K, Uusitalo T, Blom M, Konttinen YT, Nordstrom D

Publisher: INFORMA HEALTHCARE

: 2014

: Scandinavian Journal of Rheumatology

: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

: SCAND J RHEUMATOL

: 43

: 5

: 434

: 434

: 1

: 0300-9742

DOI: https://doi.org/10.1136/annrheumdis-2014-eular.2568